NSEShareholders meeting4d ago · 27 Aug 2026, 02:26 pm

Shareholders meeting

Tatva Chintan Pharma Chem Limited · TATVA

✦ AI Summaryshareholders_meeting

Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026

Attachments (1)

📄

TATVA_27082026142556_NFY26.pdf

pdf

Download →
View document text
Date:27August 2026 Ref.No.:TCPCL/SEC/2026-27/00038 TheGeneralManager, TheManager, Corporaterelationshipdepartment, Listingdepartment, BSELimited NationalStockExchangeofIndiaLimited PhirozeJeejeebhoyTowers, ExchangePlaza,C-1,Block-G, DalalStreet,Fort, Bandra-KurlaComplex,Bandra(E), Mumbai-400001 Mumbai-400051 ScripCode:543321 ScripSymbol:TATVA Subject: Notice of the 30th Annual General Meeting (“AGM”) of the Company as requiredunderRegulation30oftheSEBI(ListingObligationsandDisclosure Requirements)Regulations,2015(“SEBIListingRegulations”) DearSir/Madam, Pursuant to Regulation 30 of the SEBI Listing Regulations, please find enclosed herewith Notice alongwithExplanatoryStatement ofthe 30th AGMof the Members oftheCompany scheduled to be held on Friday, 25 September 2026 at 04:00 p.m. (IST) through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM"). The said Notice forms partoftheAnnualReport2025-26. The Notice of the 30th AGM of the Company is also available on the website of the Companyatwww.tatvachintan.com. Kindlytaketheaboveinformationonrecord. Thankingyou, Yoursfaithfully, ForTatvaChintanPharmaChemLimited IshwarNayi CompanySecretaryandComplianceOfficer M.No.:A37444 Encl.:AsAbove Notice NOTICE IS HEREBY GIVEN THAT THE THIRTIETH (30TH) ANNUAL including from Central Government, if any, as may be required, GENERAL MEETING (“AGM”) OF THE MEMBERS OF TATVA CHINTAN Mr. Chintan Nitinkumar Shah (DIN: 00183618) be and is PHARMA CHEM LIMITED (“THE COMPANY”) WILL BE HELD ON hereby re-appointed as Managing Director of the Company FRIDAY, 25 SEPTEMBER 2026 AT 04:00 P.M. (IST) THROUGH VIDEO to act as such, for a further period of three (3) years from CONFERENCING (“VC”) / OTHER AUDIO VISUAL MEANS (“OAVM”) 01 February 2027 to 31 January 2030 (both days inclusive), TO TRANSACT THE FOLLOWING BUSINESSES: liable to retire by rotation, with substantial powers of management of the affairs of the Company as of a Managing ORDINARY BUSINESS: Director, as defined under Section 2(54) of the said Act, but subject to the superintendence, direction and control of 1. T o receive, consider and adopt the Audited Standalone the Board of Directors of the Company; on the terms and Financial Statements of the Company for the financial year conditions of appointment and remuneration as set out in the ended 31 March 2026, together with the Reports of the Board explanatory statement annexed to the Notice convening this of Directors and the Auditors thereon. Meeting, with a liberty and power to the Board of Directors of the Company (including its Committee constituted for the 2. T o receive, consider and adopt the Audited Consolidated purpose) to alter and vary the terms and conditions of the Financial Statements of the Company for the financial year said re-appointment as agreed by and between the Board of ended 31 March 2026, together with the Report of the Directors and Mr. Chintan Nitinkumar Shah. Auditors thereon. R ESOLVED FURTHER THAT notwithstanding anything 3. T o declare dividend on equity shares for the financial year contained to the contrary in the Companies Act, 2013, ended 31 March 2026. wherein any financial year the Company has no profits or inadequate profit, Mr. Chintan Nitinkumar Shah shall be paid 4. To appoint a Director in place of Mr. Shekhar Rasiklal Somani remuneration, perquisites and / or allowances as stated in the (DIN: 00183665) who retires by rotation and being eligible, explanatory statement as minimum remuneration. offers himself for re-appointment. R ESOLVED FURTHER THAT in the event of any statutory SPECIAL BUSINESS: amendment or modification by the Central Government to 5. R e-appointment of Mr. Chintan Nitinkumar Shah (DIN: Schedule V of the Companies Act, 2013, the Board of Directors 00183618), as the Managing Director of the Company for a be and are hereby authorized to vary and alter the terms of period of three (3) years with effect from 01 February 2027 appointment including salary, allowances, perquisites etc. and fixation of remuneration. payable to Mr. Chintan Nitinkumar Shah within such prescribed limit or ceiling and as agreed by and between the Company and To consider and, if thought fit, to pass with or Mr. Chintan Nitinkumar Shah without any further reference by without modification(s), the following Resolution as a the Company in General Meeting. Special Resolution: R ESOLVED FURTHER THAT pursuant to the prescribed “RESOLVED THAT pursuant to the provisions of Sections 152, provisions of Regulation 17(6)(e) of the SEBI (Listing 196, 197, 198, 203 read with Schedule V and other applicable Obligations and Disclosure Requirements) Regulations, 2015 provisions, if any, of the Companies Act, 2013 (“the Act”) (“SEBI Listing Regulations”) and other applicable regulations, and the Rules made thereunder [including any statutory and subject to the maximum remuneration approved by modification(s) or re-enactment(s) thereof for the time being the members, approval of the Members of the Company in force] and as per relevant provisions of the Securities and be and is hereby accorded for payment of remuneration to Exchange Board of India (Listing Obligations and Disclosure Mr. Chintan Nitinkumar Shah, Managing Director, Promoter Requirements) Regulations, 2015 (“SEBI Listing Regulations”), of the Company as per the requirements of Regulation 17(6) as amended from time to time (including any amendments (e) of the SEBI Listing Regulations. thereto or re-enactment thereof, for the time being in force) (hereinafter collectively referred to as the “Applicable Laws”) R ESOLVED FURTHER THAT the Board of Directors of the and the Articles of Association of the Company and as approved Company (including its Committee thereof) be and is hereby and recommended by the Nomination and Remuneration authorised to do all such acts, deeds, matters and things as Committee and by the Board of Directors of the Company and may be necessary, expedient and desirable for the purpose of subject to such other approvals, permissions and sanctions giving effect to this resolution.” Annual Report 2025-26 1 6. R e-appointment of Mr. Ajaykumar Mansukhlal Patel (DIN: R ESOLVED FURTHER THAT pursuant to the prescribed 00183745), as the Whole-time Director of the Company for provisions of Regulation 17(6)(e) of the SEBI (Listing Obligations a period of three (3) years with effect from 01 February 2027 and Disclosure Requirements) Regulations, 2015 (“SEBI Listing and fixation of remuneration. Regulations”) and other applicable regulations, and subject to the maximum remuneration approved by the members, To consider and, if thought fit, to pass with or approval of the Members of the Company be and is hereby without modification(s), the following Resolution as a accorded for payment of remuneration to Mr. Ajaykumar Special Resolution: Mansukhlal Patel, Whole-time Director, Promoter of the Company as per the requirements of Regulation 17(6)(e) of “RESOLVED THAT pursuant to the provisions of Sections 152, the SEBI Listing Regulations. 196, 197, 198, 203 read with Schedule V and other applicable provisions, if any, of the Companies Act, 2013 (“the Act”) R ESOLVED FURTHER THAT the Board of Directors of the and the Rules made thereunder [including any statutory Company (including its Committee thereof) be and is hereby modification(s) or re-enactment(s) thereof for the time being authorised to do all such acts, deeds, matters and things as in force] and as per relevant provisions of the Securities and may be necessary, expedient and desirable for the purpose of Exchange Board of India (Listing Obligations and Disclosure giving effect to this resolution.” Requirements) Regulations, 2015 (“SEBI Listing Regulations”), as amended from time to time (including any amendments 7. R e-appointment of Mr. Shekhar Rasiklal Somani (DIN: thereto or re-enactment thereof, for the time being in force) 00183665), as the Whole-time Director of the Company for (hereinafter collectively referred to as th [Showing first 8,000 characters — download PDF for full document]